Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurology ; 51(1): 120-4, 1998 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9674789

RESUMO

OBJECTIVE: To determine the best therapeutic strategy for the use of midodrine in patients with neurogenic orthostatic hypotension (NOH). BACKGROUND: Midodrine is a peripherally acting alpha-adrenergic agonist useful in the treatment of NOH. However, neither the most effective dosage of midodrine nor the required frequency of administration is established. DESIGN/METHODS: Midodrine dose-blood pressure response, pharmacokinetics, and duration of action were examined in a double-blind, placebo-controlled, four-way crossover trial. Twenty-five patients with NOH were randomized to receive on successive days placebo or midodrine 2.5, 10, or 20 mg. Blood pressures of patients in the supine and standing positions were measured sequentially. A global assessment of the patient's overall symptom improvement after each leg of the study was performed. Blood levels of midodrine and its active metabolite, desglymidodrine, were assayed. RESULTS: Midodrine significantly increased standing systolic blood pressure, with the increase peaking at 1 hour. There was a significant linear relation between midodrine dosage and mean systolic blood pressure. The mean score for global improvement of symptoms was significantly higher for midodrine (10 and 20 mg) compared with placebo. The half-life of desglymidodrine was approximately 4 hours. CONCLUSION: A 10-mg dose of midodrine prescribed two to three times daily is effective in increasing orthostatic blood pressure and ameliorating symptoms in patients with NOH.


Assuntos
Agonistas alfa-Adrenérgicos/administração & dosagem , Doenças do Sistema Nervoso Autônomo/tratamento farmacológico , Hipotensão Ortostática/tratamento farmacológico , Midodrina/administração & dosagem , Agonistas alfa-Adrenérgicos/farmacocinética , Adulto , Idoso , Doenças do Sistema Nervoso Autônomo/complicações , Estudos Cross-Over , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Hipotensão Ortostática/etiologia , Masculino , Pessoa de Meia-Idade , Midodrina/farmacocinética
3.
Bull Math Biol ; 59(3): 483-96, 1997 May.
Artigo em Inglês | MEDLINE | ID: mdl-9172825

RESUMO

In searching for strong homologies between multiple nucleic acid or protein sequences, researchers commonly look at fixed-length segments in common to the sequences. Such homologies form the foundation of segment-based algorithms for multiple alignment of protein sequences. The researcher uses settings of "unusualness of multiple matches" to calibrate the algorithms. In applications where a researcher has found a multiple matching word, statistical significance helps gauge the unusualness of the observed match. Previous approximations for the unusualness of multiple matches are based on large sample theory, and are sometimes quite inaccurate. Section 2 illustrates this inaccuracy, and provides accurate approximations for the probability of a common word in R out of R sequences. Section 3 generalizes the approximation to multiple matching in R out of S sequences. Section 4 describes a more complex approximation that incorporates exact probabilities and yields excellent accuracy; this approximation is useful for checking the simpler approximations over a range of values.


Assuntos
DNA/química , Proteínas/química , RNA/química , Homologia de Sequência de Aminoácidos , Homologia de Sequência do Ácido Nucleico , Matemática , Modelos Estatísticos , Probabilidade , Distribuição Aleatória , Reprodutibilidade dos Testes
4.
JAMA ; 277(13): 1046-51, 1997 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-9091692

RESUMO

OBJECTIVE: To evaluate the efficacy of a 10-mg dose of midodrine 3 times per day in improving blood pressure (BP) and ameliorating symptoms of orthostatic hypotension in patients with neurogenic orthostatic hypotension. Midodrine hydrochloride, an alpha-agonist, could improve orthostatic BP by increasing vasomotor and venomotor tone. DESIGN/METHODS: A total of 171 patients with orthostatic hypotension participated in a multicenter, randomized, placebo-controlled study. They were randomized to a 10-mg dose of midodrine or placebo 3 times per day in a 6-week study, comprising single-blind run-in (at week 1) and washout at weeks 5 and 6, with an intervening double-blind period (weeks 2 to 4). SETTING: Twenty-five centers, with most patients evaluated in referral centers. MAIN OUTCOME MEASURES: The primary end points were improvement in standing systolic BP, symptoms of lightheadedness, and a global symptom relief score (by the investigator and patient separately). RESULTS: Nine patients were not evaluable because of noncompliance or taking concomitant vasoactive medications (3 in the midodrine group, 6 in the placebo group). In the evaluable patients, midodrine resulted in improvements in standing systolic BP at all time points (P<.001 at visits 2, 3, 4, and 5), in reported symptoms by the end of the second week of treatment (P=.001), and in the global symptom relief score rated by both the patient (P=.03) and the investigator (P<.001). There was no effect by center, severity of orthostatic hypotension, use of fludrocortisone or compression garments, or diagnosis. The main adverse effects were those of pilomotor reactions, urinary retention, and supine hypertension. CONCLUSIONS: Midodrine is efficacious and safe in the treatment of neurogenic orthostatic hypotension.


Assuntos
Agonistas alfa-Adrenérgicos/uso terapêutico , Hipotensão Ortostática/tratamento farmacológico , Midodrina/uso terapêutico , Simpatomiméticos/uso terapêutico , Vasoconstritores/uso terapêutico , Atividades Cotidianas , Agonistas alfa-Adrenérgicos/efeitos adversos , Análise de Variância , Tontura , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Midodrina/efeitos adversos , Simpatomiméticos/efeitos adversos , Sístole , Vasoconstritores/efeitos adversos
5.
Bull Math Biol ; 56(6): 1143-62, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7833847

RESUMO

Given two independent sequences of letters, we seek the probability distribution of the length of the longest matching word. This word can be in different positions in the two sequences and we consider both perfect and nearly perfect matching. We derive bounds and approximations for the probability and compare them with other bounds and approximations. The results can be applied to DNA sequences in molecular biology and generalized matching between two independent random sequences.


Assuntos
Sequência de Bases , DNA/química , Matemática , Modelos Estatísticos , Reconhecimento Automatizado de Padrão , Probabilidade , Distribuição Aleatória
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...